Suppr超能文献

1例费城染色体阳性急性淋巴细胞白血病伴1q部分三体,涉及13号染色体作为受体——一项新的细胞遗传学发现

A case of Philadelphia chromosome positive acute lymphoblastic leukemia with partial trisomy of chromosome 1q involving chromosome 13 as the acceptor-A novel cytogenetic finding.

作者信息

Bharadwaj Mohit, Sharma Anurag, Katara Rahul, Pradhan Dinesh, Arora Raman, Mittal Reena, Mohanty Sambit K

机构信息

Department of Pathology, CORE Diagnostics, Gurgaon, Haryana, India.

University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

出版信息

Pathol Res Pract. 2017 Jan;213(1):72-74. doi: 10.1016/j.prp.2016.08.016. Epub 2016 Sep 4.

Abstract

The Philadelphia (Ph) chromosome is infrequently found in acute lymphoblastic leukemia and is associated with poor prognosis. We present a case of Ph chromosome positive B cell-acute lymphoblastic leukemia with the partial trisomy of chromosome 1q involving chromosome 13 as the acceptor which has never been reported in the English literature. Jumping translocation (JT) of chromosome 1 is rare and is associated with disease progression and poor prognosis. Herein, we report the first case of Ph chromosome positive B cell-acute lymphoblastic leukemia with coexisting jumping translocation of chromosome 1 leading to trisomy of chromosome 1q. Dismal prognosis associated with synchronous presence of a Ph chromosome and JT leading to a partial trisomy of chromosome 1q may carry significant prognostic and therapeutic implications. This may be an incidental finding and further studies with large patient cohorts and clinical outcomes are needed to definitively determine the predictive value of this cytogenetic finding.

摘要

费城(Ph)染色体在急性淋巴细胞白血病中很少见,且与预后不良相关。我们报告了1例Ph染色体阳性的B细胞急性淋巴细胞白血病病例,该病例存在1号染色体部分三体,其易位受体涉及13号染色体,英文文献中尚未有过此类报道。1号染色体的跳跃易位(JT)很罕见,与疾病进展和预后不良有关。在此,我们报告首例Ph染色体阳性的B细胞急性淋巴细胞白血病合并1号染色体跳跃易位导致1q染色体三体的病例。Ph染色体与JT同时存在导致1q染色体部分三体,这种情况预后不佳,可能具有重要的预后和治疗意义。这可能是一个偶然发现,需要对大量患者队列及临床结果进行进一步研究,以明确这一细胞遗传学发现的预测价值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验